BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
153 hedge funds and large institutions have $263M invested in BioDelivery Sciences International, Inc. in 2020 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 53 increasing their positions, 52 reducing their positions, and 28 closing their positions.
2% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 52
4% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 28
3% less funds holding
Funds holding: 157 → 153 (-4)
40% less capital invested
Capital invested by funds: $439M → $263M (-$176M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
85% less call options, than puts
Call options by funds: $106K | Put options by funds: $724K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$30.4M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$8.05M |
| 3 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$5.86M |
| 4 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
+$4.25M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$7.3M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5.26M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$5.05M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$4.14M |
| 5 |
D.E. Shaw & Co
New York
|
-$3.48M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DWA
176
Dorsey Wright & Associates
Pasadena,
California
| – | -$16K | -2,512 | Closed |
|
|
AS
177
Altshuler Shaham
Tel Aviv,
Israel
| – | -$13K | -2,089 | Closed |
|
178
Walleye Capital
New York
| – | -$10K | -1,500 | Closed |
|
|
GWM
179
Geneos Wealth Management
Englewood,
Colorado
| – | -$3K | -500 | Closed |
|
|
VCM
180
Versant Capital Management
Phoenix,
Arizona
| – | +$246 | +50 | New |
|
|
TRCT
181
Tower Research Capital (TRC)
New York
| – | +$491 | +100 | New |
|
BDSI Hedge Fund Activity: Q1 2020 in Review
153 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q1 2020, worth a combined $263M — down 40% from $439M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of BDSI and 27 opened new positions — a net loss of 1 holder — while 52 trimmed existing stakes and 53 added.
The largest buyer was Deerfield Management, opening a new position worth an estimated $30.4M. The largest seller was Morgan Stanley, cutting an estimated $7.3M.
- 153 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q1 2020, down from 157 in Q4 2019.
- Funds reported $263M of BioDelivery Sciences International, Inc. stock for Q1 2020, down 40% quarter-over-quarter.
- 27 funds opened new BioDelivery Sciences International, Inc. positions in Q1 2020 and 28 closed out, a net change of -1 holder.
- The largest BioDelivery Sciences International, Inc. buyer in Q1 2020 was Deerfield Management, an estimated $30.4M added.
- The largest BioDelivery Sciences International, Inc. seller in Q1 2020 was Morgan Stanley, an estimated $7.3M sold.
Based on aggregated 13F filings for Q1 2020.